Neurotorium Neurotorium
  • About us
  • 3D Brain Atlas
  • Outreach & Partnerships
  • Clinical Education Grants
  • Contact
  • Login

  • Epilepsy
  • Anxiety
  • Depression
  • Parkinson’s
  • Bipolar
  • Stroke
  • All themes
  • Epilepsy
  • Anxiety
  • Depression
  • Parkinson’s Disease
  • Bipolar Disorder
  • Stroke
  • Alzheimer’s Disease
  • All themes
  • About us
  • 3D Brain Atlas
  • Outreach & Partnerships
  • Clinical Education Grants
  • Contact
  • Login
  • Slide Decks
  • Epilepsy – Treatment principles
  • Narrow- vs broad-spectrum ASMs for newly diagnosed patients

Narrow- vs broad-spectrum ASMs for newly diagnosed patients

Epilepsy

Lamotrigine and oxcarbazepine are known to occasionally aggravate myoclonic seizures and are therefore not recommended.1,4

References:

1.Löscher W, Klein P. The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS Drugs 2021; 35 (9): 935‒963.

2.Cheng JY, French JA. Intelligent use of antiepileptic drugs is beneficial to patients. Curr Opin Neurol 2018; 31 (2): 169‒175.

3.Guerrini R, Balestrini S, Wirrell EC, Walker MC. Monogenic epilepsies: Disease mechanisms, clinical phenotypes, and targeted therapies. Neurology 2021; 97 (17): 817‒831.

4.Kanner AM, Bicchi MM. Antiseizure medications for adults with epilepsy: A review. JAMA 2022; 327 (13): 1269–1281.

file_download Download slide in HQ
Published 26.11.2025
Permissions

Sign up for our newsletter

Stay up to date with the latest content on Neurotorium.

Neurotorium

Neurotorium was founded by the Lundbeck Foundation lundbeckfonden.com.

About
  • Disclaimer and privacy policy
  • Accessibility statement for Neurotorium
  • Contact
  • About us
  • Sign Up
Follow us
facebook-link instagram-link twitter-link linkedin-link youtube-link bluesky-link

© 2026 Neurotorium, all rights reserved

References
Share or print

Share content with anyone.

Options

email print
Link to this post
https://neurotorium.org/slidedeck/epilepsy-treatment-principles/slide/11-narrow-vs-broad-spectrum-asms-for-newly-diagnosed-patients/
copy done
Save to workspace

Sign up for our newsletter

Fill in you information below and stay up to date with the latest content on Neurotorium.

Please enter your name
Please enter your surname
Please enter your email

If you don't receive a welcome email, please check your spam folder. You can unsubscribe at any time by clicking the link in our emails. Read our Disclaimer and privacy policy for more information.

Welcome back

Please enter your details below.

Invalid e-mail
Invalid password
I don't have an account

task_alt